We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GLIN:NYSE ARCAVanEck India Growth Leaders ETF Analysis

Data as of 2026-05-19 - not real-time

$44.03

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

GLIN currently trades at $44.03, sitting just above the identified support of $43.60 and below the 20‑day SMA of $45.16, indicating limited upside in the immediate window. The 14‑day RSI at 45.35 signals a neutral momentum, while the MACD shows a bearish divergence (MACD line 0.106 vs signal 0.324, negative histogram), suggesting downward pressure may persist. Volatility has spiked to a 30‑day rate of 25.2%, and the YTD return is –2.70%, reflecting recent market turbulence. However, the fund’s beta of 0.68 points to lower sensitivity to broader market swings, and the expense ratio of 0.72% remains competitive for an emerging‑market focused ETF.
On the liquidity front, trading volume is increasing, yet average volumes remain modest, implying that sizable trades could move the price. The fund tracks its index with zero tracking error and no discount/premium, providing transparent exposure to Indian growth leaders. With the Fear & Greed Index in “Extreme Greed” territory, market sentiment is broadly bullish, but the ETF’s technical indicators caution against a rushed entry. Investors should therefore align actions with their time horizon: short‑term caution, medium‑term patience, and long‑term confidence in India’s growth trajectory.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • price hovering just above support
  • bearish MACD divergence
  • elevated short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • neutral RSI and low beta indicating manageable market exposure
  • zero tracking error ensures index fidelity
  • increasing volume suggests potential breakout

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • India’s long‑term growth outlook
  • low beta reduces systematic risk
  • competitive expense ratio and zero tracking error

Key Metrics & Analysis

Fund Metrics

Expense Ratio0.72%
AUM$100.2M
Inception Date2010-08-24
Avg Daily Volume9,650
Premium/Discount0.00%
Tracking Error0.00%
Dividend Yield0.86%

Technical Analysis

TrendNeutral
RSI45.4
Support$43.60
Resistance$46.99
MA 20$45.16
MA 50$43.71
MA 200$45.19
MACDBearish
VolumeIncreasing
Fear & Greed Index89.61

Risk Assessment

Beta0.68
Volatility25.18%
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.